Dermata Therapeutics, Inc. DRMA
0.57 USD -0.03 (-4.75%)
Regular-session close
0.57 0.00 +0.02%
Pre-market · Nov 18, 4:39 AM ET
0.57 Day range 0.68
0.566 52-week range 4.66
- YTD
- -75.43%
- 1 year
- -79.93%
News
benzinga.com Dermata Therapeutics Says Additional Results From Recently Completed Cosmetic Study Further Support Marketing Of Tome Foundational Treatment For Skin Renewal Additional Study FindingsDermata's recently completed cosmetic clinical study consisted of 31 participants in an open label study of Tome Foundational Treatment. Participants applied Tome…
benzinga.com Dermata Therapeutics Q3 EPS $(0.55), Inline Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(0.55) per share which met the analyst consensus estimate. This is a 66.67 percent increase over losses of $(1.65) per share from the…
benzinga.com Dermata Therapeutics Enrolls First Participant In Its Clinical Trial Evaluating Tome Clearing Treatment For Acne; Expects To Launch This Second Commercial Product In H1 2027 The initiation of this clinical trial marks another milestone in Dermata's strategy by adding a second product to its Tome skincare portfolio, targeting significant opportunities in the consumer…
